CIHR Projects

Browse 3998 CIHR-funded research projects

Search & Filter Projects
Clear All
Showing 101-150 of 3998 projects

PI: Sirbu, Olga I

Medulloblastoma is the most common cancerous brain tumour in children-one out of five childhood brain tumours are medulloblastoma. While the majority of ill health and death occurs due to metastasis,…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Xie, Irene Yuning

Pancreatic cancer is a lethal disease that typically presents at the advanced or metastatic stage. Chemotherapy remains the mainstay of treatment, but finding a targeted therapy has been a challenge …

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Lamarche, Jani

Fear of cancer recurrence (FCR) is common, persistent, and is associated with negative physical and mental health outcomes. Family caregivers (FC) of cancer patients experience equal or greater level…

Unclear Clinical
$105,000
Year: 2021
Cancer Research
View Details

PI: Pullella, Katherine

Arsenic is an established carcinogen for the skin, bladder and lungs; however, the impact of arsenic exposure on cancer risk at other sites, including the breast, remains inconclusive. Recently, our …

Unclear Social / Cultural / Envi…
$105,000
Year: 2021
Cancer Research
View Details

PI: Shapovalov, Ivan

Metastatic cancer spread is the cause of poor prognosis in cancer. Canadian statistics show that patients with non-metastatic breast cancer have a 90% 3-year survival chance, but patients with metast…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Molter, Clayton W

Regardless of mutational origin, in all cancers, cells must change their biophysical characteristics to migrate through fibrous multicellular environments. As such, cell softening and increased cell-…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Fukano, Marina

Breast cancer is the most diagnosed and second deadliest cancer among women in Canada after lung cancer. Triple-negative breast cancer (TNBC) is a subtype of breast cancer that lacks known breast can…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Heney, Kayla

Melanoma is the deadliest form of skin cancer, arising from the cancerous transformation of the melanocytes, the pigment producing cells of the skin. In 5-10% of sun-exposed melanoma patients, a recu…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Desharnais, Lysanne

Immune checkpoint inhibitors are a type of cancer therapy that targets your immune system's natural ability to fight cancer. This treatment has been revolutionary for lung cancer, which is often diag…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Romero, Joan Miguel

Pancreatic cancer is the 3rd leading cause of cancer deaths, with less than 10% of patients surviving this cancer. An important reason for this lethality is that pancreatic cancer does not respond we…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Ferrier, Sarah T

Head and neck cancer includes cancers of the mouth, tonsils, throat, and voice box. It can be caused by smoking and drinking, but also by infection with a virus called Human Papillomavirus (HPV). Whi…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Lagace, Francois

Background: Cutaneous melanoma (CM) causes more deaths than any other skin cancer. In Canada, CM is the 8th most commonly diagnosed cancer and the number of CM cases is increasing. There are many wel…

Unclear Social / Cultural / Envi…
$105,000
Year: 2021
Cancer Research
View Details

PI: Valic, Michael S

The development of nanoparticles for personalised anti-cancer medicine has reached a breakneck pace in papers published and patents submitted. However, few of these nanoparticle candidates will survi…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Liu, Zhe Qi

Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer and has the lowest 5-year patient survival rate of all major cancer types. Immunotherapy is an increasingly promis…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Tajik, Amanda

Acute myeloid leukemia is an aggressive form of blood cancer. Although remission after initial treatment is common, for many patients the disease returns, oftentimes in a more aggressive and treatmen…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: MacDonald, Kate

When our cells are exposed to DNA-damaging agents, such as UV light from the sun or the chemotherapeutic drugs commonly used for cancer treatment, pieces of DNA can break off from our chromosomes. Th…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Harb, Sami I

To help manage the biopsychosocial consequences of cancer, many patients receive care from informal caregivers who are unpaid family members or friends. But with the onset of COVID-19, caregivers are…

Unclear Health systems / services
$105,000
Year: 2021
Cancer Research
View Details

PI: Vanstone, Ruth N

Although survival rates after cancer diagnosis and treatment continue to rise, the experience of cancer can pose challenges well into survivorship. Women of childbearing age who are diagnosed with ca…

Unclear Health systems / services
$105,000
Year: 2021
Cancer Research
View Details

PI: Panichnantakul, Pudchalaluck

The preservation of genetic material is essential for cell proliferation and survival. Unstable or damaged DNA can result in mutations and subsequently contribute to diseases which include a multitud…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Lee, Stacey N

Natural Killer (NK) cells are cells of the immune system that can identify and kill unhealthy cells by using markers that label cells as healthy or unhealthy. Cancer cells are good at using certain m…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: MacLean, Leah K

Lung cancer is the most common cause of cancer death worldwide and Nova Scotia demonstrates the highest incidence rate of all Canadian provinces. Most lung cancer patients have a subtype that falls u…

Unclear Clinical
$105,000
Year: 2021
Cancer Research
View Details

PI: Kapcan, Eden

The immune system is trained at recognizing and killing dangerous objects in your body. These dangerous objects could be bacteria, viruses, or cancer. Sometimes cancer is able to evade the immune sys…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: CHEN, HE TIAN

Leukemias originate from the accumulation of mutations within hematopoietic stem cells, which are responsible for replenishing blood and immune cells for the body. Mild, pre-leukemic mutations in the…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Portillo, Ana

Breast cancer is the most common cancer affecting women worldwide. Triple negative breast cancer (TNBC) accounts for 12-15% of cases, and is the most aggressive form of breast cancer with the highest…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Sutherland, Robert

Colorectal cancer (CRC) is the second most common cancer in Canada and is the second and third leading cause of cancer-related death among men and women, respectively. New cases of CRC are declining …

Unclear Clinical
$105,000
Year: 2021
Cancer Research
View Details

PI: McLaughlin, Emma C

Background: Approximately 300,000 children are diagnosed with cancer annually. Treatments result in significant negative side effects. Physical activity (PA) is safe, beneficial, and feasible for chi…

Unclear Social / Cultural / Envi…
$105,000
Year: 2021
Cancer Research
View Details

PI: Daun, Julia T

Individuals with brain cancer lack access to an exercise oncology program that can address their unique physical and psychological needs. The Alberta Cancer Exercise - Neuro-Oncology (ACE-Neuro) stud…

Unclear Clinical
$105,000
Year: 2021
Cancer Research
View Details

PI: Charron, Jeremie

Il est bien connu maintenant que la pratique régulière d'activité physique permet de diminuer considérablement le risque de développer plusieurs cancers, mais on en sait très peu sur son efficacité c…

Unclear Clinical
$105,000
Year: 2021
Cancer Research
View Details

PI: Ng, Deanna

Gastric adenocarcinoma (GCa) is one of the leading causes of cancer death globally. One of the distinguishing features of GCa is its propensity to spread into the peritoneal layer of the abdominal ca…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Lin, Chien-feng

Cancer is a leading cause of death worldwide across all demographics. In cancer, there is a "loss of control" (i.e., dysregulation) of genes essential for regulating cell growth. MYC is a protein tha…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Psarianos, Pamela

Li-Fraumeni Syndrome (LFS) is a genetic condition which drastically increases the risk of developing a spectrum of early-onset cancers. 1 in 5000 people are affected by LFS, and 80% of LFS patients a…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Choi, Woo Jin

Intrahepatic cholangiocarcinoma (iCCA) is a type of bile duct cancer located inside the liver. iCCA is the second most common cause of liver cancers and only 10% of those who are diagnosed with this …

Unclear Clinical
$105,000
Year: 2021
Cancer Research
View Details

PI: Chow, Jonathan T

As of 2019, 1 in 9 Canadian men are estimated to be diagnosed with prostate cancer (PCa) in their lifetime, which represents the most common cancer diagnosis in Canadian men and fourth most common ca…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Okhovatian, Sargol

Every year, there are about 20 million new cancer cases and about 10 million cancer deaths. This devastating disease, which is caused by mutation and abnormal proliferation of cells, often leads to t…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Iqbal, Javaid

The COVID-19 pandemic has provided a test of whether the Canadian health care system can accommodate a health crisis and continue to deliver equitable, high-quality end-of-life cancer care. Although …

Unclear Health systems / services
$105,000
Year: 2021
Cancer Research
View Details

PI: DeCarlo, Alexandria L

Medulloblastoma is the most common malignant paediatric brain tumour and is currently treated with surgery, external beam radiation and chemotherapy. Current treatments are debilitating to the develo…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Rothenbroker, Meghan A

Traditional therapeutic cancer vaccine approaches typically involve injecting cancer patients with antigens (molecules that can trigger an immune response) specific to their own tumors, along with im…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Squires, Lauren R

People diagnosed with cancer who are Two-Spirit, lesbian, gay, bisexual, transgender, or queer (2SLGBTQ+) often experience cancer differently from their counterparts who are cisgender and/or heterose…

Unclear Social / Cultural / Envi…
$105,000
Year: 2021
Cancer Research
View Details

PI: Voisin, Mathew

Gliomas represent the vast majority of malignant brain tumors and include a diverse range of pathologies that all share one common feature: they are incurable. When gliomas recur after treatment, the…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Klassen, Pamela

Inoperable pancreatic cancer (IPC) is a terminal diagnosis with distressing symptoms including diarrhea, bloating and weight loss. Pancreatic tumors block the path of digestive enzymes, causing poor …

Unclear Clinical
$105,000
Year: 2021
Cancer Research
View Details

PI: Teng, Katie

Many healthy adult tissues, such as the breast and skin, contain cells that carry mutations that accumulate with age and are linked to cancer development. Although many cells are known to be mutated …

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Jamalkhah Choshali, Monire

Breast Cancer is the second most common cancer in Canada and the most common cancer among Canadian females. Poly(ADP-ribose) polymerase inhibitors have been approved by Food and Drug Administration f…

Unclear Biomedical
$150,000
Year: 2021
Cancer Research
View Details

PI: Passos Gibson, Victor

Glioblastoma multiforme (GBM) is the most common and lethal primary malignant brain tumour, with patients having a median survival rate of fewer than 15 months. Moreover, the first-line approved ther…

Unclear Biomedical
$150,000
Year: 2021
Cancer Research
View Details

PI: Lauener, Madeline

Hematopoietic Stem Cell Transplantation (HSCT), the infusion of a donors immune system into a recipient, is an important immune-based therapy for patients with high-risk and recurring blood cancers. …

Unclear Biomedical
$150,000
Year: 2021
Cancer Research
View Details

PI: Voisin, Mathew

Gliomas represent the vast majority of malignant brain tumors and include a diverse range of pathologies that all share one common feature: they are incurable. When gliomas recur after treatment, the…

Unclear Biomedical
$150,000
Year: 2021
Cancer Research
View Details

PI: Sorin, Mark

Lung cancer is the greatest cause of cancer-related death worldwide, accounting for about 25% of all cancer-related fatalities. Indeed, more people die from lung cancer than breast, colon and pancrea…

Unclear Biomedical
$150,000
Year: 2021
Cancer Research
View Details

PI: Romero, Joan Miguel

Pancreatic cancer is the 3rd leading cause of cancer deaths, with less than 10% of patients surviving this cancer. An important reason for this lethality is that pancreatic cancer does not respond we…

Unclear Biomedical
$150,000
Year: 2021
Cancer Research
View Details

PI: Kong, Tim

Myeloproliferative neoplasms (MPNs) are a group of blood cancers/leukemias in which there is overproduction of one or more types of blood cells and affect ~5/100,000 persons. Polycythemia vera and es…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Wong, Alan Y

Leukemia is the most common childhood cancer and the second greatest cause of pediatric cancer mortality in Canada. Chemotherapy directed to the central nervous system (CNS) is a critical part of tre…

Unclear Biomedical
$105,000
Year: 2021
Cancer Research
View Details

PI: Haddad, Elie

Rhabdomyosarcoma (RMS) is the most common soft tissue cancer in childhood. Although progress in treatments have led to a remission rate of approximatively 60% of all pediatric cases, the prognosis of…

Unclear Biomedical
$460,000
Year: 2021
Cancer Research
View Details